2002

Bengtson, J, Adolphson, M, Brewer, DL, Jacobs, D, Gard, JL, Cahoon, L, Bloom, M, Kennelly, B, Porter, K, Kmonicek, J, Krainin, FM, Shane, J, Marquis, JF, Kearns, SA, Moliterno, DJ, DeSantis, P, Ohman, EM, Martz, C, Brown, DL, Bulley, M, Worley, S, Slovak, J, Hollywood, L, Knepper, K, and Browne, K (2002).
Multicenter, dose-ranging study of efegatran sulfate versus heparin with thrombolysis for acute myocardial infarction: The Promotion of Reperfusion in Myocardial Infarction Evolution (PRIME) trial
.

Benjamin, DK (2002).
Integration of statistical theory and practical clinical expertise. Polymerase chain reaction testing of the HIV-exposed infant
.

Berger, PB, Mahaffey, KW, Meier, SJ, Buller, CE, Batchelor, W, Fry, ET, and Zidar, JP (2002).
Safety and efficacy of only 2 weeks of ticlopidine therapy in patients at increased risk of coronary stent thrombosis: Results from the Antiplatelet Therapy alone versus Lovenox plus Antiplatelet therapy in patients at increased risk of Stent Thrombosis (ATLAST) trial
.

Berlin, JA, Santanna, J, Schmid, CH, Szczech, LA, and Feldman, HI (2002).
Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head
.

Bethel, MA and Feinglos, MN (2002).
Insulin analogues: new therapies for type 2 diabetes mellitus
.

Billgren, T, Birnbaum, Y, Sgarbossa, EB, Sejersten, M, Hill, NE, Engblom, H, Maynard, C, Pahlm, O, and Wagner, GS (2002).
Detailed definition and interobserver agreement for the electrocardiographic Sclarovsky-Birnbaum ischemia grading system
.

Birnbaum, Y, Mahaffey, KW, Criger, DA, Gates, KB, Barbash, GI, Barbagelata, A, Clemmensen, P, Sgarbossa, EB, Gibbons, RJ, Rahman, MA, Califf, RM, Granger, CB, and Wagner, GS (2002).
Grade III ischemia on presentation with acute myocardial infarction predicts rapid progression of necrosis and less myocardial salvage with thrombolysis
.

Blankenship, JC, Balog, C, Sapp, SK, Califf, RM, Lincoff, AM, Tcheng, JE, and Topol, EJ (2002).
Reduction in vascular access site bleeding in sequential abciximab coronary intervention trials
.

Blumenthal, JA, Babyak, M, Wei, J, O'Connor, C, Waugh, R, Eisenstein, E, Mark, D, Sherwood, A, Woodley, PS, Irwin, RJ, and Reed, G (2002).
Usefulness of psychosocial treatment of mental stress-induced myocardial ischemia in men
.

Boersma, E, Harrington, RA, Moliterno, DJ, White, H, and Simoons, ML (2002).
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes
.

Boersma, E, Harrington, RA, Moliterno, DJ, White, H, Theroux, P, Van, de, de, To, Armstrong, PW, Wallentin, LC, Wilcox, RG, Simes, J, Califf, RM, Topol, EJ, and Simoons, ML (2002).
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials
.

Bohjanen, PR, Johnson, MD, Szczech, LA, Wray, DW, Petros, WP, Miller, CR, and Hicks, CB (2002).
Steady-state pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with end-stage renal disease receiving chronic dialysis
.

Booker, KJ, Drew, BJ, Lux, RL, Johanson, P, Krucoff, MW, Hampton, D, Hubelbank, M, Feild, DQ, Stadler, RW, and Mortara, DM (2002).
The first ISCE board of "Trustees" overview panel session: Ischemia monitoring, state of the art
.

Bourque, JM, Velazquez, EJ, Borges-Neto, S, Hasselblad, V, and O'Connor, CM (2002).
A reappraisal of myocardial viability testing in patients with coronary artery disease and left ventricular dysfunction: can meta-analysis be trusted?
.

Braunwald, E, Antman, EM, Beasley, JW, Califf, RM, Cheitlin, MD, Hochman, JS, Jones, RH, Kereiakes, D, Kupersmith, J, Levin, TN, Pepine, CJ, Schaeffer, JW, Smith, EE, Steward, DE, Theroux, P, Gibbons, RJ, Alpert, JS, Faxon, DP, Fuster, V, Gregoratos, G, Hiratzka, LF, Jacobs, AK, and Smith, SC (2002).
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina)
.

Braunwald, E, Antman, EM, Beasley, JW, Califf, RM, Cheitlin, MD, Hochman, JS, Jones, RH, Kereiakes, D, Kupersmith, J, Levin, TN, Pepine, CJ, Schaeffer, JW, Smith, EE, Steward, DE, Theroux, P, Gibbons, RJ, Alpert, JS, Faxon, DP, Fuster, V, Gregoratos, G, Hiratzka, LF, Jacobs, AK, and Smith, SC (2002).
ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina)
.

Breeman, A, Mercado, N, Lenzen, M, van, de, Harrington, RA, Califf, RM, Topol, EJ, Simoons, ML, and Boersma, E (2002).
Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy)
.

Brener, SJ, Zeymer, U, Adgey, AA, Vrobel, TR, Ellis, SG, Neuhaus, KL, Juran, N, Ivanc, TB, Ohman, EM, Strony, J, Kitt, M, and Topol, EJ (2002).
Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction - The integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial
.

Brummett, BH, Babyak, MA, Mark, DC, Williams, RB, Siegler, IC, Clapp-Channing, N, and Barefoot, JC (2002).
Predictors of smoking cessation in patients with a diagnosis of coronary artery disease
.

Buell, HE, Stables, RH, DeLong, ER, Shuping, KB, Killip, DM, Lever, HM, McKenna, WJ, Rubin, D, Sigwart, U, Takayama, M, Wagner, GS, Eisenstein, EL, and Spencer, WH (2002).
Percutaneous transluminal septal reduction for hypertrophic obstructive cardiomyopathy: report from an international pilot study
.

Burns, BJ (2002).
Reasons for Hope: A Perspective and Overview
.

Burns, BJ, Compton, SN, Egger, HL, Farmer, EM, and Robertson, EB (2002).
An Annotated Bibliography of Evidence for Diagnostic-Specific Psychosocial and Psychopharmacological Interventions
.

Buxton, AE, Lee, KL, Hafley, GE, Wyse, DG, Fisher, JD, Lehmann, MH, Pires, LA, Gold, MR, Packer, DL, Josephson, ME, Prystowsky, EN, and Talajic, MR (2002).
Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial
.

Cabell, CH and Abrutyn, E (2002).
Progress toward a global understanding of infective endocarditis. Early lessons from the International Collaboration on Endocarditis investigation
.

Cabell, CH, Jollis, JG, Peterson, GE, Corey, GR, Anderson, DJ, Sexton, DJ, Woods, CW, Reller, LB, Ryan, T, and Fowler, VG (2002).
Changing patient characteristics and the effect on mortality in endocarditis
.